Insider Trading June 25, 2026 05:57 PM

TTM Technologies Executive Sells Shares Amid Corporate Expansion

President Robert P. Farrell liquidates portion of holdings for tax obligations as the company navigates index migration and strategic acquisitions.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
TTMI

Robert P. Farrell, President of C&C at TTM Technologies Inc. (NASDAQ:TTMI), executed a sale of 2,920 shares on June 23, 2026. The transaction, valued at approximately $612,597, was conducted under a pre-established 10b5-1 trading plan adopted earlier in the year. The sales were specifically designated to cover tax liabilities arising from the vesting of restricted stock units. This executive activity occurs against a backdrop of significant corporate developments for TTM Technologies, including an upcoming migration to the Russell 1000 Index and the opening of a new defense electronics facility in Syracuse, New York. The company is also pursuing strategic acquisitions to bolster its capabilities in the medical, aerospace, and defense sectors.

TTM Technologies Executive Sells Shares Amid Corporate Expansion
TTMI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Robert P. Farrell sold 2,920 shares of TTM Technologies for approximately $612,597 to cover tax liabilities from vesting restricted stock units.
  • TTM Technologies is set to migrate from the Russell 2000 Index to the Russell 1000 Index, impacting large-cap equity benchmarks.
  • The company is expanding its defense and aerospace capabilities through a new $130 million facility and strategic acquisitions of Swiss Technology Group AG and ILFA GmbH.

Robert P. Farrell, serving as President of C&C at TTM Technologies Inc. (NASDAQ:TTMI), completed a transaction involving the sale of 2,920 shares of common stock on June 23, 2026. The aggregate value of these shares fell within the range of $612,597, with individual share prices recorded between $201.95 and $213.39 during the execution of the trades.

Farrell executed these sales in accordance with a 10b5-1 trading plan that he formally adopted on February 25, 2026. Filing documentation explicitly states that the purpose of these transactions was solely to satisfy tax liabilities associated with the vesting of restricted stock units. Following the completion of this sale, Farrell's direct ownership in TTM Technologies common stock stands at 16,486 shares.

The timing of this executive transaction coincides with a period of elevated valuation for TTM Technologies. The company's shares are currently trading near their 52-week high of $223.83, reflecting a substantial 435% return over the preceding twelve months. At the time of the sale, the stock was priced at $210.57, resulting in a market capitalization of $21.66 billion. Market analysis indicates that the stock may be overvalued relative to its estimated fair value, placing it among companies flagged for this characteristic.

Concurrently, TTM Technologies is navigating significant structural and operational changes. The company is scheduled to migrate from the Russell 2000 Index to the Russell 1000 Index, a move effective after market close. This transition aligns TTM Technologies with benchmarks typically associated with large-cap U.S. equities. Furthermore, the company has inaugurated a new $130 million defense electronics facility in Syracuse, New York. This project involves a $30 million investment from the U.S. Department of Defense and is designed to produce advanced circuit boards for aerospace and defense applications.

In the realm of corporate development, TTM Technologies has announced plans to acquire Swiss Technology Group AG and ILFA GmbH through separate all-cash transactions, subject to regulatory approvals. These acquisitions are intended to expand the company's operational capabilities within the medical, aerospace, and defense industries. Additionally, the company's Mini-Xinger product portfolio has secured AEC-Q200 qualification accreditation, confirming its adherence to stringent stress testing and reliability standards required for automotive and high-reliability applications.

Risks

  • The stock is currently trading near its 52-week high, which may present valuation risks if growth expectations are not met.
  • The acquisitions of Swiss Technology Group AG and ILFA GmbH are pending regulatory approvals, introducing execution uncertainty.
  • Migration to the Russell 1000 Index may alter the company's investor base and liquidity dynamics.

More from Insider Trading

Aditxt Shareholder Liquidates Entire Stake as Stock Plummets Amid Corporate Restructuring Jun 25, 2026 EverCommerce Executive Transaction and Q1 Financial Review Jun 25, 2026 Nurix Therapeutics CSO Gwenn Hansen Sells Stock Amid Clinical Progress and Roche Partnership Jun 25, 2026 Nurix Therapeutics Executive Sells Shares Amid Clinical Milestones and Strategic Partnership Jun 25, 2026 OUTFRONT Media Executive Sells Shares Under Pre-Arranged Plan Jun 25, 2026